DalsnaFinance Account

Ventas $VTR

Real Estate · Health Care REITs · NYSE/NASDAQ

S&P 500 Russell 1000 Illinois

Create a scorecard

$80.76

-1.10 (-1.34%)

As of Oct 7, 2026, 2:52 PM EDT

Price history

Loading chart…

Ventas (VTR) is trading down at $80.76 (-1.34%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Real Estate sector.

Ventas revenue & net income history (FY2016–FY2025)

RevenueNet income

Ventas annual financial statements
	FY2016Dec 2016	FY2017Dec 2017	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$3.44B	$3.57B	$3.75B	$3.87B	$3.80B	$3.83B	$4.13B	$4.50B	$4.92B	$5.83B
Growth (year over year)	+4.8%	+3.8%	+4.8%	+3.4%	−2.0%	+0.9%	+7.9%	+8.9%	+9.5%	+18.5%
Net income	$649.2M	$1.36B	$409.5M	$433.0M	$439.1M	$49.0M	−$47.4M	−$41.0M	$81.2M	$251.4M
Net margin	18.9%	38.0%	10.9%	11.2%	11.6%	1.3%	−1.1%	−0.9%	1.6%	4.3%
EPS (diluted)	$1.86	$3.78	$1.14	$1.17	$1.17	$0.13	−$0.12	−$0.10	$0.19	$0.54
Balance sheet
Cash and equivalents	$286.7M	$81.4M	$72.3M	$106.4M	$413.3M	$149.7M	$122.6M	$508.8M	$897.9M	$741.1M
Total assets	$23.2B	$24.0B	$22.6B	$24.7B	$23.9B	$24.7B	$24.2B	$24.7B	$26.2B	$27.6B
Total liabilities	$12.4B	$12.9B	$12.1B	$13.9B	$13.4B	$13.5B	$13.7B	$14.9B	$15.0B	$14.6B
Long-term debt	$11.1B	$11.3B	$10.7B	$12.2B	$11.9B	$12.0B	$12.3B	$13.5B	$13.5B	$13.0B
Shareholders' equity	$10.5B	$10.9B	$10.2B	$10.4B	$10.2B	$10.9B	$10.2B	$9.49B	$10.8B	$12.5B
Cash flow
Operating cash flow	$1.35B	$1.43B	$1.38B	$1.44B	$1.45B	$1.03B	$1.12B	$1.12B	$1.33B	$1.65B
Capital expenditure	$117.5M	$132.6M	$131.9M	$156.7M	$607.3M	$1.80B	$900.7M	$649.5M	$2.53B	$2.93B
Free cash flow	$1.24B	$1.30B	$1.25B	$1.28B	$842.9M	−$775.9M	$219.5M	$470.4M	−$1.20B	−$1.28B
Dividends paid	$1.02B	$827.3M	$1.13B	$1.16B	$928.8M	$686.9M	$720.3M	$723.6M	$740.3M	$860.1M

RevenueNet income

Ventas quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$1.24B	$1.29B	$1.36B	$1.42B	$1.49B	$1.57B	$1.66B	$1.73B
Growth (year over year)	+7.5%	+10.5%	+13.2%	+18.3%	+20.4%	+21.7%	+22.0%	+21.7%
Net income	$19.2M	$56.8M	$46.9M	$68.3M	$66.0M	$70.2M	$55.9M	$70.6M
Net margin	1.6%	4.4%	3.5%	4.8%	4.4%	4.5%	3.4%	4.1%
EPS (diluted)	$0.05	$0.13	$0.10	$0.15	$0.14	$0.15	$0.11	$0.14
Balance sheet
Cash and equivalents	$1.10B	$897.9M	$182.3M	$614.2M	$188.6M	$741.1M	$183.6M	$199.0M
Total assets	$25.3B	$26.2B	$26.0B	$26.5B	$26.9B	$27.6B	$27.7B	$29.7B
Total liabilities	$15.2B	$15.0B	$14.2B	$14.6B	$14.2B	$14.6B	$14.1B	$14.4B
Long-term debt	—	$13.5B	—	—	—	$13.0B	—	—
Shareholders' equity	$9.76B	$10.8B	$11.5B	$11.5B	$12.4B	$12.5B	$13.1B	$14.6B
Cash flow
Operating cash flow	$353.7M	$373.6M	$321.1M	$475.3M	$378.6M	$471.7M	$394.6M	$556.5M
Dividends paid	$186.2M	$189.0M	$199.0M	$217.0M	$218.4M	$225.7M	$230.2M	$253.3M

From Ventas's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Ventas

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom.

Source: Wikipedia — Ventas (company)